Board Meeting

26 March 2025

Agenda

• Welcome and opening

  Review of agenda
• 2025 goals review
• Revenue Q1 progress

  Results vs. objectives, trend analysis and projections
• Team

  Progress on hiring open vacancies, challenges and solutions
• Product direction

  Algorithm performance KPIs, platforms (iframe, app, clinical trials, SALT), branded calculators
• Regulatory certification

  Status of FDA approval, status of ANVISA approval, next steps
• Questions, comments, and next steps